A detailed history of New England Capital Financial Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, New England Capital Financial Advisors LLC holds 14 shares of LLY stock, worth $10,964. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14
Previous 14 -0.0%
Holding current value
$10,964
Previous $12.8 Million 2.01%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 06, 2023

SELL
$434.7 - $599.3 $43,904 - $60,529
-101 Reduced 87.83%
14 $7.58 Million
Q1 2023

May 04, 2023

BUY
$310.63 - $364.82 $4,659 - $5,472
15 Added 15.0%
115 $39.3 Million
Q4 2022

Feb 03, 2023

BUY
$321.55 - $374.67 $32,155 - $37,467
100 New
100 $34.8 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track New England Capital Financial Advisors LLC Portfolio

Follow New England Capital Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Capital Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on New England Capital Financial Advisors LLC with notifications on news.